A detailed history of Lpl Financial LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Lpl Financial LLC holds 1,449,611 shares of ABT stock, worth $168 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,449,611
Previous 1,394,423 3.96%
Holding current value
$168 Million
Previous $145 Million 14.06%
% of portfolio
0.08%
Previous 0.07%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$100.07 - $118.13 $5.52 Million - $6.52 Million
55,188 Added 3.96%
1,449,611 $165 Million
Q2 2024

Aug 07, 2024

BUY
$100.73 - $112.44 $10.4 Million - $11.6 Million
103,248 Added 8.0%
1,394,423 $145 Million
Q1 2024

May 10, 2024

BUY
$109.52 - $120.96 $7.32 Million - $8.08 Million
66,830 Added 5.46%
1,291,175 $147 Million
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $6.06 Million - $7.42 Million
67,186 Added 5.81%
1,224,345 $135 Million
Q3 2023

Nov 13, 2023

BUY
$95.53 - $114.62 $8.64 Million - $10.4 Million
90,406 Added 8.47%
1,157,159 $112 Million
Q2 2023

Jul 31, 2023

BUY
$100.78 - $112.29 $4.7 Million - $5.24 Million
46,680 Added 4.58%
1,066,753 $116 Million
Q1 2023

May 10, 2023

BUY
$96.86 - $114.01 $10.7 Million - $12.6 Million
110,378 Added 12.13%
1,020,073 $103 Million
Q4 2022

Feb 07, 2023

BUY
$95.06 - $111.52 $1.91 Million - $2.24 Million
20,088 Added 2.26%
909,695 $99.9 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $2.5 Million - $2.89 Million
25,818 Added 2.99%
889,607 $86.1 Million
Q2 2022

Aug 12, 2022

BUY
$102.07 - $123.37 $6.55 Million - $7.92 Million
64,208 Added 8.03%
863,789 $93.9 Million
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $2.16 Million - $2.64 Million
18,960 Added 2.43%
799,581 $94.6 Million
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $5.49 Million - $6.73 Million
47,563 Added 6.49%
780,621 $110 Million
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $6.97 Million - $7.71 Million
59,733 Added 8.87%
733,058 $86.6 Million
Q2 2021

Aug 13, 2021

BUY
$105.79 - $124.53 $1.98 Million - $2.33 Million
18,723 Added 2.86%
673,325 $78.1 Million
Q1 2021

May 14, 2021

SELL
$108.84 - $128.23 $3.69 Million - $4.35 Million
-33,917 Reduced 4.93%
654,602 $78.4 Million
Q4 2020

Feb 12, 2021

BUY
$105.0 - $114.42 $6.16 Million - $6.72 Million
58,689 Added 9.32%
688,519 $75.4 Million
Q3 2020

Nov 09, 2020

BUY
$91.64 - $111.29 $4.37 Million - $5.3 Million
47,653 Added 8.19%
629,830 $68.5 Million
Q2 2020

Aug 13, 2020

BUY
$76.57 - $98.0 $8.87 Million - $11.3 Million
115,779 Added 24.82%
582,177 $53.2 Million
Q1 2020

May 14, 2020

SELL
$62.82 - $91.86 $128,969 - $188,588
-2,053 Reduced 0.44%
466,398 $36.8 Million
Q4 2019

Feb 14, 2020

BUY
$78.51 - $87.4 $735,560 - $818,850
9,369 Added 2.04%
468,451 $40.7 Million
Q3 2019

Nov 13, 2019

BUY
$81.84 - $88.74 $357,640 - $387,793
4,370 Added 0.96%
459,082 $38.4 Million
Q2 2019

Aug 09, 2019

BUY
$72.88 - $85.0 $960,121 - $1.12 Million
13,174 Added 2.98%
454,712 $38.2 Million
Q1 2019

May 08, 2019

BUY
$66.22 - $80.06 $1.74 Million - $2.1 Million
26,209 Added 6.31%
441,538 $35.3 Million
Q4 2018

Feb 07, 2019

SELL
$65.56 - $74.27 $483,832 - $548,112
-7,380 Reduced 1.75%
415,329 $30 Million
Q3 2018

Nov 14, 2018

BUY
$60.81 - $73.36 $2.07 Million - $2.49 Million
33,984 Added 8.74%
422,709 $31 Million
Q2 2018

Aug 14, 2018

BUY
$57.57 - $63.54 $362,921 - $400,556
6,304 Added 1.65%
388,725 $23.7 Million
Q1 2018

May 15, 2018

BUY
$56.27 - $63.62 $1.12 Million - $1.27 Million
19,957 Added 5.51%
382,421 $22.9 Million
Q4 2017

Feb 14, 2018

BUY
$53.68 - $57.47 $492,030 - $526,770
9,166 Added 2.59%
362,464 $20.7 Million
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $127,407 - $142,199
2,651 Added 0.76%
353,298 $18.9 Million
Q2 2017

Aug 14, 2017

BUY
N/A
350,647
350,647 $17 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.